Advertisement

Medtronic obtains expanded indication for snoring treatment system
Medtronic (NYSE:MDT), a Minneapolis, Minn.-based company, received expanded FDA clearance for the Pillar Palatal devices, used to treat patients with severe snoring problems. While this device was already approved for the U.S. market, this new clearance allows for up to 5 devices to be placed in patients with wider mouths or softer palate tissue.

This is good news for the company, which laid off nearly 1,000 employees in May following declines in its cardiac rhythm management and spinal products.
Read more

Advertisement
Advertisement